Quanterix Corp (QTRX) Stock Analysis

Quanterix Corp (QTRX) is a publicly traded company in the HEALTHCARE sector. It trades at $3.50, carries a market capitalization of $164.87M. This page summarizes the public market data, fundamentals, and frequently asked questions for QTRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $3.50
• Market Cap: $164.87M
• EPS: $-2.35
• 52-Week High: $8.77
• 52-Week Low: $2.40

Market Sentiment

Quanterix Corp currently has a Neutral sentiment score of -0.04.

About Quanterix Corp

Quanterix Corporation is a leading life sciences innovator based in Billerica, Massachusetts, focused on revolutionizing precision health through its advanced digital immunoassay platforms. The company's proprietary technology allows for ultra-sensitive biomarker detection, empowering research and diagnostics in a variety of therapeutic areas and driving advancements in disease understanding and personalized patient care. With a strong global presence across North America, Europe, the Middle ...

GNG Research Analysis

GNG Research scores Quanterix Corp (QTRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for QTRX.

Frequently Asked Questions

Does QTRX pay dividends?

Quanterix Corp (QTRX) does not currently pay a regular dividend.

What is QTRX's market cap?

Quanterix Corp (QTRX) has a market capitalization of $164.87M with a current stock price of $3.50.